Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Interest Expenses (2021 - 2026)

Shuttle Pharmaceuticals Holdings has reported Non Operating Interest Expenses for 6 years, with the latest figure at $12122.0 in Q1 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 85.49% year-over-year to $12122.0 in Q1 2026; TTM through Mar 2026 was $14317.0, a 102.97% increase from a year earlier, with the FY2025 full-year figure at $8730.0, changed 0.44% from the prior year.
• Non Operating Interest Expenses was $12122.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$35117.0 in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $623465.0 in Q3 2023, with the low at -$1.2 million in Q4 2024.
• Average Non Operating Interest Expenses over 5 years is $158938.9, with a median of $170391.0 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses soared 6245.34% in 2023, then slumped 796.33% in 2024.
• Over 5 years, Non Operating Interest Expenses stood at -$2781.0 in 2022, then jumped by 6245.34% to $170902.0 in 2023, then plunged by 796.33% to -$1.2 million in 2024, then soared by 97.05% to -$35117.0 in 2025, then jumped by 134.52% to $12122.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $12122.0 (Q1 2026), -$35117.0 (Q4 2025), and $18183.0 (Q3 2025), per Business Quant data.